Lack of evidence raises questions on long-term PPI use
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
From the President: For 25 years, accreditation has paved the way
For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.
Medicine shortage reports to be mandatory
New legislation passed on Monday night introduces mandatory reporting of shortages of all prescription medicines as well as other medicines deemed vital for public...
Pharmacists can have a big impact on men’s mental health
A recent report released by Beyond Blue has further revealed the state of men’s mental health in Australia. Pharmacists can help to intervene before...
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
